Showing results (501-510 of 2,459) with videos related to
Sort By:
Pageof 246
Viral Immunology|March 17, 2004
Avidity of antibodies to cytomegalovirus in HIV-seropositive patients with and without CMV retinitisBeth C Marshall, Mark A Jacobson, Stuart P Adler, et al.Life Sciences|April 15, 2004
Effects of the allosteric modulator SCH-202676 on adenosine and P2Y receptorsZhan-Guo Gao, Ariel S Gross, Kenneth A JacobsonThe American Journal of Medicine|June 6, 1994
Fluvastatin and niacin in hypercholesterolemia: a preliminary report on gender differences in efficacyT A Jacobson, L A Jokubaitis, L F AmorosaLife Sciences|January 1, 1992
High affinity acylating antagonists for muscarinic receptorsJ Baumgold, Y Karton, N Malka, et al.American Journal of Ophthalmology|May 1, 1995
Dose-related difference in progression rates of cytomegalovirus retinopathy during foscarnet maintenance therapy. AIDS Clinical Trials Group Protocol 915 TeamG N Holland, R D Levinson, M A JacobsonJournal of Developmental and Behavioral Pediatrics : JDBP|October 16, 2015
Sleep Difficulties are Associated with Parent Report of Sluggish Cognitive TempoTaylor A Koriakin, E Mark Mahone, Lisa A JacobsonExpert Review of Cardiovascular Therapy|August 1, 2008
Clinical characterization and molecular mechanisms of statin myopathyPeter P Toth, Charles R Harper, Terry A JacobsonThe Journal of Nutrition|October 24, 2006
Flaxseed oil supplementation does not affect plasma lipoprotein concentration or particle size in human subjectsCharles R Harper, Megan C Edwards, Terry A JacobsonWiley Interdisciplinary Reviews. Membrane Transport and Signaling|January 22, 2013
Molecular Structure of P2Y Receptors: Mutagenesis, Modeling, and Chemical ProbesKenneth A Jacobson, M P Suresh Jayasekara, Stefano CostanziPharmacology Communications|November 7, 2014
TRIFUNCTIONAL LIGANDS: A RADIOIODINATED HIGH AFFINITY ACYLATING ANTAGONIST FOR THE A1 ADENOSINE RECEPTORKenneth A Jacobson, Mark E Olah, Gary L StilesPageof 246